← capex_spike (all companies) · AIM (all signals) · all methodology
capex_spike on AIM ImmunoTech Inc. (AIM)
SIC 2836 — Biological Products, (No Diagnostic Substances) · CIK 946644 · default direction: short
Definition
Fires on >50% YoY capex increase. Captures aggressive reinvestment phases — often precedes value destruction in mature industries.
Every time the signal fired on AIM
| FY | Filing date | Event date | 1d | 5d | 20d | 60d | 252d |
|---|---|---|---|---|---|---|---|
| FY2022 | 2023-03-31 | 2023-03-31 | -2.33% | -4.65% | +6.98% | +37.21% | +11.63% |
| FY2021 | 2022-03-31 | 2022-03-31 | +0.00% | -2.83% | -0.94% | -19.81% | -60.38% |
| FY2019 | 2020-03-30 | 2020-03-30 | -3.76% | +7.14% | -18.42% | -14.66% | -19.55% |
| FY2018 | 2019-04-01 | 2019-04-01 | +0.00% | +6.25% | +31.25% | -37.93% | -63.64% |
| FY2012 | 2013-03-18 | 2013-03-18 | -4.76% | -4.76% | +4.76% | +28.57% | +90.48% |
| FY2011 | 2012-03-14 | 2012-03-14 | +0.00% | +22.58% | +9.68% | -9.68% | -32.26% |
Forward returns are stock returns from event date (next trading day after filing). Sign is raw stock direction; the trade direction is in the calibration table below.
Universe-wide calibration (this signal across all companies)
| Horizon | n events | Gross stock ret | Hit rate | Trade dir | Net PnL | Cost (bps) | r/σ net |
|---|---|---|---|---|---|---|---|
| 1d | 2,295 | +0.01% | +43.27% | short | -0.06% | 32 | -0.01 |
| 5d | 2,292 | -0.85% | +41.88% | short | +0.74% | 33 | +0.06 |
| 20d | 2,258 | -1.91% | +41.67% | short | +2.05% | 36 | +0.10 |
| 60d | 2,127 | +0.65% | +44.01% | short | -0.78% | 47 | -0.02 |
| 252d | 2,092 | +14.03% | +44.93% | short | -14.91% | 97 | -0.09 |
Net PnL is direction × stock return − round-trip execution cost (5 bps half-spread + ADV-tiered borrow). See capex_spike methodology for the full audit.